Detalhe da pesquisa
1.
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Cell
; 187(7): 1617-1635, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552610
2.
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial.
Lancet
; 401(10378): 733-746, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36764316
3.
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations.
Int J Mol Sci
; 24(16)2023 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37629023
4.
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.
Cancer Immunol Immunother
; 71(2): 327-337, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34164709
5.
Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.
Future Oncol
; 18(28): 3151-3164, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929414
6.
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.
Acta Oncol
; 59(9): 1058-1063, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762415
7.
Atezolizumab Treatment of Nonsquamous NSCLC.
N Engl J Med
; 379(12): 1187, 2018 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30260156
8.
Therapies in the pipeline for small-cell lung cancer.
Br Med Bull
; 119(1): 37-48, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27325208
9.
Novel therapies for advanced squamous cell carcinoma of the lung.
Future Oncol
; 12(5): 659-67, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26880383
10.
Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms.
Future Oncol
; 12(4): 551-64, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26776915
11.
Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future Challenges.
J Thorac Oncol
; 19(2): 199-215, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783386
12.
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial.
J Clin Oncol
; 42(2): 180-191, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37788412
13.
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.
J Clin Oncol
; : JCO2302166, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552197
14.
MET alterations in NSCLC-Current Perspectives and Future Challenges.
J Thorac Oncol
; 18(4): 419-435, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441095
15.
First-line immunotherapy in non-small cell lung cancer: how to select and where to go.
Expert Rev Respir Med
; 17(12): 1191-1206, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294292
16.
Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challenges.
Nat Rev Clin Oncol
; 20(10): 664-677, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488229
17.
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients.
Anticancer Res
; 43(6): 2799-2812, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247889
18.
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.
Anticancer Res
; 43(5): 2243-2258, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097667
19.
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
JTO Clin Res Rep
; 4(1): 100433, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36793384
20.
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion.
J Thorac Oncol
; 18(5): 576-586, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36646211